Determined shorts use any kind of news item or press
Determined shorts use any kind of news item or press release to try to suppress stock price, so they can say "See, no one trusts this company" -- exactly so that people will post "The stock is going down on good news, there must not be any shorts out there lying about the company, or else it would have gone up. No, there's something wrong, it must have been overpriced to start with..."
or other similar nonsense. I've seen this many times before, with other companies. No matter how good the news, it's portrayed as problematic. Why help them out, by setting a high target?
I will be thrilled if there is a huge contract that brings a lot of income to the company. But I am certainly not going to make assumptions about the size of this first sale. As I said, anything is a victory.
The science is good. The company is on the right track. I'm making no assumptions about how large a purchase this will be.
1
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...
Continue Reading
AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...
Continue Reading
A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...
Continue Reading
Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...
Continue Reading
Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....
Continue Reading
You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...
Continue Reading
History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...
Continue Reading
Top 5 Most Recently Viewed Articles
Analyzing F5 Inc.'s Stock Metrics In today's market, F5 Inc. (NASDAQ: FFIV) is trading at $315.70 after experiencing a slight decrease of 0.48%. Interestingly, over the past month, the company has seen its stock rise by 5.50%, and in the last year, it has impressively increased by 58.08%. This growth prompts shareholders to contemplate whether the stock's current...
Continue Reading
Exploring New Horizons: Jeffs’ Brands' Non-Binding MOU The 3D, AI-Powered Technology Screens 25,000 People Per Hour—Without Stopping Them In an exciting development for Jeffs' Brands Ltd (“Jeffs’ Brands” or the “Company”) (NASDAQ: JFBR, JFBRW), a leading data-driven e-commerce firm leveraging the Amazon Marketplace, the company has announced its wholly owned...
Continue Reading
Understanding Pain Awareness Month September signals National Pain Awareness Month, a significant time to shed light on the challenges and treatment options for managing pain. Chronic pain impacts millions worldwide, deeply affecting day-to-day life. In particular, lower back pain is alarming, affecting over 619 million people globally according to recent statistics....
Continue Reading
Pier 88 Health and Theranica Revolutionize Migraine Treatment Pier 88 Health, a pioneer in digital health, and Theranica have announced a significant advancement in migraine treatment. Their groundbreaking product, the Nerivio® REN wearable, is now approved by China's National Medical Products Administration (NMPA), marking a pivotal moment for those suffering from this...
Continue Reading
Experience the Vibrant CARNIVALE 2026 Celebration Grace Cathedral, the cherished Episcopal landmark, is proud to announce the return of its spectacular Mardi Gras gala, CARNIVALE 2026. This exciting event is scheduled for February 13, 2026, promising to be a grand festive evening filled with joy and celebration. The Theme: Noite de Carnaval This year's theme, Noite de...
Continue Reading